You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國藥科技股份(08156.HK)溢價26.1%發行1億元可換股債券 淨籌1億元
阿思達克 08-23 09:12
國藥科技股份(08156.HK)訂立認購協議,向兩名認購人發行本金總額1億元可換股債券,年利率7厘,初步換股價為每股換股股份0.29元,較認購協議日股份收市價0.23元溢價26.1%。 若相關股份根據初步換股價獲全數轉換,可轉換為3.45億股,佔擴大後股本7.26%。 公司表示,發行可換股債券所得款項淨額料為1億元,其中3,500萬元用於發展及推廣防偽業務,另外2,000萬元擬用作償還貸款及其他應付款項,其餘4,500萬元將用作營運成本及一般營運資金。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account